View
120
Download
0
Category
Preview:
Citation preview
Indian Pharmaceutical RegulationsA current regulatory overview
Prepared by: Sambhujyoti Das
2
Indian Pharmaceutical Sector – An Overview
One of the high performing knowledge based segments of the manufacturing sector.• The ‘organised’ sector of India’s pharmaceutical industry consists of about 300 companies.
• The total sector is estimated at nearly 20,000 businesses.
• 400 + bulk drugs are produced.
• Producing high quality generic medicines that are sold around the world.
• Supplying 20% (value wise) of the global market for generic medicines.
• Exporting medicine to over 200 countries.
• Total review around US$ 20 bn +.
• Compound annual growth rate of 20 percent.
3
+
Regulatory Framework
As per Drugs & Cosmetic Act 1940.
4
Proposed New Drug Regulatory System
• Formation of Central Drug Authority (CDA) in January 2007.
• The organisational structure of CDA would be similar to US FDA.
• It would be strong, well equipped, empowered, independent and professionally managed.
• It would facilitate upgradation of the national drugs regulator, uniformity of licencing and
improvement in drug regulations.
• Strict enforcement of GMP standards to builds up trust of its clients and the obligation on
the regulatory bodies.
• Training and technical capacity building and provide necessary know how to help
manufacturer with GMP compliance.
• Focus on inspection, pharmacovigilance and drug enforcement activities.
5
Proposed New Drug Regulatory System
CDA(Central Drug
Administration)
CDSCO(Central Drug Standard Control
Organization)
SDRA(State Drug Regulatory Agency)
Central independent body under Ministry of Health &
Family Welfare
Central body
State entity
6
Roles and Responsibilities
7
Regulatory Reforms
MANPOWER Creation of new
posts. Capability & skill
development through trainings.
Optimum utilization of current staff.
INFRASTRUCTURE Expansion of zonal &
sub zonal offices. Strengthening of
central & state drug testing labs.
Expansion of current pharmacovigilance programmes.
INSPECTIONS CDA grants Mfg. license.
Establish surveillance against suspected persons.
Strict adherence to scheduled standards.
8
Regulatory Reforms
FINANCE
Additional fund to CDA INDEPENDENT
REGULATOR Efficient, strong & effective CDA.
Autonomous organization under DCGI.TRANSPARENCY & 3RD
PARTY OVERSIGHT Traceable distribution
channel. Awareness program to
customers. Drug information on
internet. Press release against
noncomplying products and organizations.
ADE reporting through internet.
Questions and discussion
THANK YOU
Recommended